Archives

Adma Biologics CEO Grossman trades over $13M in company stock By Investing.com

ADMA Biologics, Inc. (NASDAQ: ) has seen significant trading activity from its CEO Adam S. Grossman, according to recent filings. Grossman was involved in acquisitions and stock disposals on Aug. 26 and 27, totaling more than $13 million in…

JJP Biologics Announces Positive Decision to Execute a First-in-Human Clinical Trial of…

This section is Partnership content providedThe content in this section is provided by Business Wire for the purposes of press release distribution on behalf of its clients. Postmedia has not reviewed the content. by Business wire…

Lonza to buy U.S. biologics site from Roche for $1.2B (OTCMKTS:LZAGF)

Swiss contract drug manufacturer Lonza (OTCPK:LZAGF) (OTCPK:LZAGY) has agreed to acquire a large-scale biologics manufacturing site in California from Roche (OTCQX:RHHBY) (OTCQX:RHHBF) for $1.2B in cash. The Genentech facility in Vacaville…